Indication · Cardiology
Heart attack (myocardial infarction)
Last checked: Nov 20, 2026Source: FDA, ClinicalTrials.gov
Devices
57
Cleared or approved since 2000
PMA and De Novo
4
Higher-risk or first-of-kind devices
Breakthrough devices
0
Authorized through June 30, 2026
Recruiting device trials
94
745 device trials in all
Devices
4 devices via PMA. PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
- TherOx Downstream System
Zoll Circulation, Inc. · PMA · System, Oxygen, Aqueous · newest 2026 · 9 decisions
3 more devices with a free account
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
- Reduced Stent Strategy Versus Conventional Percutaneous Coronary Revascularization in Patients Presenting With STEMIPivotal-lookingRecruiting
Hospital Universitario La FeAcademic, hospital or other
NCT06353594 · 1,272 participants (planned) · Start Mar 11, 2024 · Primary completion Mar 2028
Device: Primary PCI · For: ST Elevation Myocardial Infarction
Sites: Huelva, Spain; Valencia, Spain; A Coruña, Spain · 23 sites in all
744 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
Research
- Device studies on myocardial infarction across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.